2024 annual financial data
Vertex Pharmaceuticals 2024 Operating margin
Vertex Pharmaceuticals 2024 operating margin with verified reported values.
Direct answer
Operating margin was -2.11%.
Operating income was -232,900,000 USD and net income was -535,600,000 USD.
Operating cash flow was -492,600,000 USD.
Verified data
- Revenue
- 11,020,100,000 USD
- Operating income
- -232,900,000 USD
- Net income
- -535,600,000 USD
- Operating cash flow
- -492,600,000 USD